Literature DB >> 18539490

Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis.

Chen Huang1, Li-Ying Liu, Zong-Fang Li, Pei Wang, Lei Ni, Li-Ping Song, De-Hui Xu, Tu-Sheng Song.   

Abstract

The mitogen activated protein kinases (MAPK) signaling cascade plays an important role in cell life. We proved that small interfering RNAs targeting MAPK1 (siRNA-2) could inhibit HeLa cell growth, but the effects of siRNA-2 on gene expression profile were unclear. Using Affymetrix GeneChip HG-U133A 2.0, we identified the long-term changes for 48 h in gene expression profile in HeLa cell treated by siRNA-2. The results showed that expressions of 181 genes were altered by siRNA-2 and were divided into two groups: (i) one group showed downregulation by siRNA-2, including the proliferation associated genes, small G protein, cytoskeleton associated protein and extracellular matrix associated protein; and (ii) the other group showed upregulation by siRNA-2, including interferon response genes, OAS family, TRIM family and apoptosis associated genes. The results of Real-time quantitative PCR for MAPK1, NUP188, P38, STAT1, STAT2, MPL and OAS1 were consistent with that of gene chip. Two networks were found to react substantially to the downregulation of MAPK1 by siRNA-2. One of the networks regulates cell growth through cell-cycle control, apoptosis and cytoskeleton. The other network is related to interferon-like response. Our findings suggest that siRNA-mediated downregulation of MAPK1 could be an attractive strategy for cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18539490     DOI: 10.1016/j.cellbi.2008.04.019

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  6 in total

1.  Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling.

Authors:  Shaohui Hu; Zhi Xie; Akishi Onishi; Xueping Yu; Lizhi Jiang; Jimmy Lin; Hee-sool Rho; Crystal Woodard; Hong Wang; Jun-Seop Jeong; Shunyou Long; Xiaofei He; Herschel Wade; Seth Blackshaw; Jiang Qian; Heng Zhu
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

2.  PCB exposure and potential future cancer incidence in Slovak children: an assessment from molecular finger printing by Ingenuity Pathway Analysis (IPA®) derived from experimental and epidemiological investigations.

Authors:  Somiranjan Ghosh; Christopher A Loffredo; Partha S Mitra; Tomas Trnovec; Lubica Palkovicova Murinova; Eva Sovcikova; Eric P Hoffman; Kepher H Makambi; Sisir K Dutta
Journal:  Environ Sci Pollut Res Int       Date:  2017-11-15       Impact factor: 4.223

3.  Global gene expression and Ingenuity biological functions analysis on PCBs 153 and 138 induced human PBMC in vitro reveals differential mode(s) of action in developing toxicities.

Authors:  Somiranjan Ghosh; Shizhu Zang; Partha S Mitra; Svetlana Ghimbovschi; Eric P Hoffman; Sisir K Dutta
Journal:  Environ Int       Date:  2011-04-05       Impact factor: 9.621

4.  Small-interfering RNA-mediated silencing of the MAPK p42 gene induces dual effects in HeLa cells.

Authors:  Jing-Yi Yuan; Li-Ying Liu; Pei Wang; Zong-Fang Li; Lei Ni; Aiying Wang; Sheng-Xiang Xiao; Tu-Sheng Song; Chen Huang
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

5.  [Mechanism and material basis of Lianhua Qingwen capsule for improving clinical cure rate of COVID-19: a study based on network pharmacology and molecular docking technology].

Authors:  Haiyan Yan; Chuncai Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

6.  Trisomy 21 consistently activates the interferon response.

Authors:  Kelly D Sullivan; Hannah C Lewis; Amanda A Hill; Ahwan Pandey; Leisa P Jackson; Joseph M Cabral; Keith P Smith; L Alexander Liggett; Eliana B Gomez; Matthew D Galbraith; James DeGregori; Joaquín M Espinosa
Journal:  Elife       Date:  2016-07-29       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.